On of dons best talking points was to adresss the price gouging on drug costs . Medicaid is the biggest buyer, and should be able to negotiate better pricing .
But bought n paid for pols have protected big pharm.
Taking on drug costs would be an easy win for Trump . With his base , and even with Dems !
What's stopping him ? Must be the evil GOP leadership selling us out to big pharm..
I know the attention span of many of you people is less the 5 seconds...
Millennials only have a 5-second attention span for ads, says comScore CEO
BUT you ignorant uninformed idiots have to do a little research instead mouthing the same crap!
Why can't you idiots do a little research before FALLING for the same OLD CLICHED statements..."EviL" profits! Drug companies should die!
A) Where are NEW drugs going to be developed?
Cost to Develop New Pharmaceutical Drug Now Exceeds $2.5B
A benchmark report estimates that the cost of bringing a drug to market has more than doubled in the past 10 years
CSDD’s finding, a bellwether figure in the drug industry, is based on an average out-of-pocket cost of $1.4 billion and an estimate of $1.2 billion in returns that investors forego on that money during the 10-plus years a drug candidate spends in development. The center’s analysis drew from information provided by 10 pharmaceutical companies on 106 randomly selected drugs first tested in humans between 1995 and 2007.
The study concludes that another $312 million is spent on postapproval development—studies to test new indications, formulations, and dosage strengths—for a life-cycle cost of $2.9 billion,
Cost to Develop New Pharmaceutical Drug Now Exceeds $2.5B
B) So what country in this world has developed more Drugs then the USA???
Obama Care Will End Drug Advances and Europe's Free Ride (Unless China Steps in)
Ninety five percent of the new drugs coming on the market are developed for sale in the United States. They are paid for by American consumers, while other countries, such as Canada, Germany and France, free ride at our expense. The United States is the last major country that allows the market to set prices high enough to compensate pharmaceutical companies for their R&D investments. Obama Care will increasingly control pharmaceutical prices as costs rise and federal and state funds fall short. Major pharmaceutical advances will stop (How well will government labs work?), and the rest of the world will lose along with Americans.
Obama Care Will End Drug Advances and Europe's Free Ride (Unless China Steps in)
C)What is the success rate of a drug???
report released today by the biotech industry’s national trade group finds less than one of every 10 drugs that enter clinical trials is ultimately approved by the Food and Drug Administration.
The report is sponsored by the Biotechnology Innovation Organization, or BIO. Its reported success rate, of 9.6 percent, is less than the success rate cited in a widely cited
2014 study by Tufts University’s Center for the Study of Drug Development, which set the rate of success at 11.8 percent, or one in eight.
Report suggests drug-approval rate now just 1-in-10